Efficacy and safety of selamectin against <font color="red">fleas_1</font> <font color="red">and_1</font> <font color="red">heartworms_1</font> <font color="red">in_1</font> <font color="red">dogs_3</font> <font color="red">and_3</font> <font color="red">cats_3</font> <font color="red">presented_2</font> <font color="red">as_2</font> <font color="red">veterinary_3</font> <font color="red">patients_3</font> <font color="red">in_3</font> <font color="red">North_3</font> <font color="red">America_3</font> <font color="red">._3</font> 
<br>
<br> A series of randomized , controlled , masked field studies was conducted to assess the efficacy and safety of selamectin in the treatment of <font color="red">flea_1</font> <font color="red">infestations_1</font> <font color="red">on_1</font> <font color="red">dogs_2</font> <font color="red">and_2</font> <font color="red">cats_2</font> <font color="red">,_2</font> and in the prevention of <font color="red">heartworm_1</font> <font color="red">infection_1</font> <font color="red">in_1</font> <font color="red">dogs_2</font> <font color="red">._2</font> In addition , observations were made on the beneficial effect of selamectin treatment on <font color="red">dogs_1</font> <font color="red">and_1</font> <font color="red">cats_1</font> <font color="red">showing_1</font> <font color="red">signs_1</font> <font color="red">of_1</font> <font color="red">flea_2</font> <font color="red">allergy_2</font> <font color="red">dermatitis_2</font> <font color="red">(_2</font> <font color="red">FAD_2</font> <font color="red">)_2</font> <font color="red">._2</font> In all studies selamectin was applied topically , once per month , in unit doses providing a minimum dosage of 6mgkg(-1 ) . <font color="red">Dogs_4</font> <font color="red">and_4</font> <font color="red">cats_4</font> <font color="red">with_3</font> <font color="red">naturally_3</font> <font color="red">occurring_3</font> <font color="red">flea_3</font> <font color="red">infestations_3</font> <font color="red">,_3</font> <font color="red">some_3</font> <font color="red">of_3</font> <font color="red">which_3</font> <font color="red">also_3</font> <font color="red">had_3</font> <font color="red">signs_3</font> <font color="red">associated_3</font> <font color="red">with_3</font> <font color="red">FAD_3</font> <font color="red">,_3</font> <font color="red">were_1</font> <font color="red">assigned_1</font> <font color="red">randomly_1</font> <font color="red">to_1</font> <font color="red">receive_1</font> <font color="red">three_1</font> <font color="red">months_1</font> <font color="red">of_1</font> <font color="red">topical_1</font> <font color="red">treatment_1</font> <font color="red">with_1</font> <font color="red">selamectin_1</font> <font color="red">(_1</font> <font color="red">220_2</font> <font color="red">dogs_2</font> <font color="red">,_2</font> <font color="red">189_2</font> <font color="red">cats_2</font> <font color="red">)_2</font> or a positive - control product ( dogs : fenthion , n=81 ; cats : pyrethrins , n=66 ) . Selamectin was administered on days 0 , 30 , and 60 . Day 0 was defined as the day that the animal first received treatment . Flea burdens were assessed by flea comb counts and clinical evaluations of FAD were performed before treatment , and on days 14 , 30 , 60 , and 90 . On days 30 , 60 , and 90 , mean flea counts in selamectin - treated dogs were reduced by 92.1 , 99.0 , and 99.8% , and mean flea counts in fenthion - treated dogs were reduced by 81.5 , 86.8 , and 86.1% , respectively , compared with day 0 counts . Also , on days 30 , 60 , and 90 , mean flea counts in selamectin - treated cats were reduced by 92.5 , 98.3 , and 99.3% , and mean flea counts in pyrethrin - treated cats were reduced by 66.4 , 73.9 , and 81.3% , respectively , compared with day 0 counts . Selamectin also was beneficial in alleviating signs in <font color="red">dogs_1</font> <font color="red">and_1</font> <font color="red">cats_1</font> <font color="red">diagnosed_1</font> <font color="red">clinically_1</font> <font color="red">with_1</font> <font color="red">FAD_1</font> <font color="red">._1</font> A total of <font color="red">397_2</font> <font color="red">dogs_2</font> <font color="red">free_1</font> <font color="red">of_1</font> <font color="red">adult_1</font> <font color="red">heartworm_1</font> <font color="red">infection_1</font> <font color="red">from_1</font> <font color="red">four_1</font> <font color="red">heartworm_1</font> <font color="red">-_1</font> <font color="red">endemic_1</font> <font color="red">areas_1</font> <font color="red">of_1</font> <font color="red">the_1</font> <font color="red">USA_1</font> were allocated randomly to six months of treatment with selamectin ( n=298 ) or ivermectin ( n=99 ) . Selamectin achieved a heartworm prevention rate of 100% , with all dogs testing negative for microfilariae and adult heartworm antigen on days 180 and 300 . Selamectin was administered to a total of <font color="red">673_1</font> <font color="red">dogs_1</font> <font color="red">and_1</font> <font color="red">347_1</font> <font color="red">cats_1</font> having an age range of 6 weeks to 19 years ( 3954 doses ) . The <font color="red">animals_1</font> <font color="red">included_1</font> <font color="red">19_2</font> <font color="red">purebred_2</font> <font color="red">or_2</font> <font color="red">crossbred_2</font> <font color="red">Collies_2</font> <font color="red">(_2</font> <font color="red">Bearded_2</font> <font color="red">,_2</font> <font color="red">Border_2</font> <font color="red">,_2</font> <font color="red">and_2</font> <font color="red">unspecified_2</font> <font color="red">)_2</font> <font color="red">._1</font> There were no serious adverse events . Results of these studies indicated that selamectin was highly effective in the control of flea infestations in <font color="red">dogs_1</font> <font color="red">and_1</font> <font color="red">cats_1</font> without the need for simultaneous treatment of the environment or of in - contact animals and also was beneficial in alleviating signs associated with FAD . Selamectin also was 100% effective in preventing the development of canine heartworms and was safe for topical use in <font color="red">dogs_2</font> <font color="red">and_2</font> <font color="red">cats_2</font> <font color="red">._2</font>